Increased bone turnover in epileptic patients treated with carbamazepine

Annals of Neurology

Volumn 47, Issue 3, 2000, Pages 385-388

  Verrotti, Alberto ^a   Greco, Rita ^a   Morgese, Guido ^b   Chiarelli, Francesco ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTICONVULSANT ACTIVITY; ARTICLE; BONE METABOLISM; BONE TURNOVER; CLINICAL ARTICLE; DRUG EFFECT; EPILEPSY; HUMAN; MALE; OSTEOLYSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BONE AND BONES; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSIES, PARTIAL; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 0034008836     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200003)47:3<385::AID-ANA18>3.0.CO;2-W     Document Type: Article

References (20)

1. Hahn TJ, Hendin BA, Scharp CR, et al. Serum 25-hydroxycholecalciferol levels and bone mass in children on chronic anticonvulsant therapy. N Engl J Med 1976;292:550-554
2. Hunter J, Maxwell JD, Stewart DA, et al. Altered calcium metabolism in epileptic children on anticonvulsants. Br Med J 1971;23:202-204
3. Keck E, Gollnick B, Reinhart D, et al. Calcium metabolism and vitamin D metabolite levels in children receiving anticonvulsant drugs. Eur J Pediatr 1982;139:52-55
4. Ala-Houhala M, Korpela R, Koivikko M, et al. Long-term anticonvulsant therapy and vitamin D metabolism in ambulatory pubertal children. Neuropediatrics 1986;17:212-216
5. Enneking-Ivey O, Bailey LB, Gawley L, et al. Folic acid and vitamin D status of young children receiving minimal anticonvulsant drug therapy. Int J Vitam Nutr Res 1981;51:349-352
6. Risteli J, Elomaa I, Niemi S, et al. Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993;39:635-640
7. Risteli J, Niemi S, Trivedi P, et al. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988;34:715-718
8. Hanson DA, Weis ME, Bollen AM, et al. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251-1258
9. Mora S, Prinster C, Proverbio MC, et al. Urinary markers of bone turnover in healthy children and adolescents: age related changes and effect of puberty. Calcif Tissue Int 1998;63:369-374
10. Chiarelli F, Verrotti A, Tumini S, Morgese G. Effect of normal carbohydrate/low fat diet on lipid metabolism in insulin dependent diabetes mellitus in childhood. Diab Nutr Metab 1989;2: 285-289
11. Berry EM, Gupta MM, Turner SJ, Burns RR. Variations in plasma calcium with induced changes in plasma specific gravity, total protein and albumin. Br Med J 1973;4:640-645
12. Verrotti A, Basciani F, Carle F, et al. Calcium metabolism in adolescents and young adults with type I diabetes mellitus without and with persistent microalbuminuria. J Endocrinol Invest 1999;22:198-202
13. Garnero P, Delams PD. Assessment of the serum levels of bone alkaline phosphatase with new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 1993;77:1046-1053
14. Takeshita N, Seino Y, Ishida H, et al. Increased circulating levels of γ-carboxyglutamic acid-containing protein and decreased bone mass in children on anticonvulsant therapy. Calcif Tissue Int 1989;44:80-85
15. Weinstein RS, Bryce GF, Sappington LJ, et al. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J Clin Endocrinol Metab 1984;58:1003-1009
16. Tjellesen L, Nilas L, Christiansen C. Does carbamazepine cause disturbances in calcium metabolism in epileptic patients? Acta Neurol Scand 1983;68:13-19
17. Akin R, Okutan V, Sarici Ü, et al. Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol 1998;19:129-131
18. Välimaki MJ, Tiihonen M, Laitinen K, et al. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res 1994;9:631-634
19. Sheth RD, Wesolowski CA, Jacob JC, et al. Effect of carbamazepine and valproate on bone mineral density. J Pediatr 1995;127:256-262
20. O'Hare JA, Duggan B, O'Driscoll D, Callaghan N. Biochemical evidence for osteomalacia with carbamazepine therapy. Acta Neurol Scand 1980;62:282-286